Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2019
Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeksSazan Rasul, Marcus Hacker, Elisabeth Kretschmer-Chott, et al.
International Journal of Molecular Sciences|December 2, 2020
Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-AnalysisFinn Edler von Eyben, Glenn Bauman, Rie von Eyben, et al.
Molecular and Cellular Endocrinology|June 14, 2021
Sex differences in brown adipose tissue activity and cold-induced thermogenesisCarsten T Herz, Oana C Kulterer, Marlene Prager, et al.
European Journal of Medicinal Chemistry|May 25, 2019
(R)-[18F]NEBIFQUINIDE: A promising new PET tracer for TSPO imagingNeydher Berroterán-Infante, Thomas Kalina, Lukas Fetty, et al.
Annals of Surgical Oncology|September 6, 2014
Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileumHarun Ilhan, Wolfgang P Fendler, Clemens C Cyran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2012
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumorsAlexander R Haug, Ramona Cindea-Drimus, Christoph J Auernhammer, et al.
EJNMMI Research|August 13, 2016
Nephroprotective effects of enalapril after [177Lu]-DOTATATE therapy using serial renal scintigraphies in a murine model of radiation-induced nephropathyHarun Ilhan, Hao Wang, Franz J Gildehaus, et al.
European Radiology|February 28, 2015
Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancerWolfgang Peter Fendler, Harun Ilhan, Philipp M Paprottka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2015
Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissueWalter Rachinger, Veit M Stoecklein, Nicole A Terpolilli, et al.
Biomedicines|December 23, 2022
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft TumorsJohannes Zellmer, Hsi-Yu Yen, Lena Kaiser, et al.
Pageof 9